The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Intervals Longer Than 20 Weeks From Breast-Conserving Surgery to Radiation Therapy Are Associated With Inferior Outcome for Women With Early-Stage Breast Cancer Who Are Not Receiving Chemotherapy
Open accessAbstract
Purpose: To determine the interval from breast-conserving surgery (BCS) to radiation therapy (RT) that affects local control or survival. Patients and Methods: The 10-year Kaplan-Meier (KM) local recurrence-free survival (LRFS), distant recurrence-free survival (DRFS), and breast cancer–specific survival (BCSS) were computed for 6,428 women who had T1 to 2, N0 to 1, M0 breast cancer that was diagnosed in British Columbia between 1989 and 2003, and who were treated with BCS and RT without chemotherapy. Intervals from BCS to RT were grouped by weeks as follows: ≤ 4 (n = 83), greater than 4 to 8 (n = 2,288; reference group); greater than 8 to 12 (n = 2,606); greater than 12 to 16 (n = 961); greater than 16 to 20 (n = 358); and greater than 20 weeks (n = 132). Cox proportional hazards models and matching were used to control for confounding variables. Results: The median follow-up time was 7.5 years. The 10-year KM outcomes were as follows: LRFS, 95.4%; DRFS, 90.5%; and BCSS, 92.5%. Compared with the greater than 4 to 8 weeks group, hazard ratios (HR) were not significantly different for any outcome among patients who were treated up to 20 weeks after BCS. However, LRFS (hazard ratio [HR], 2.00; P = .15), DRFS (HR, 1.86; P = .02) and BCSS (HR, 2.15; P = .009) were inferior for women with BCS-to-RT intervals greater than 20 weeks compared with those greater than 4 to 8 weeks. The matched analysis yielded similar results. Conclusion: Outcomes were statistically similar for BCS-to-RT intervals up to 20 weeks, but they were inferior for intervals beyond 20 weeks. Time can be reasonably allowed for the breast to heal and for patients to consider treatment options, but RT should start within 20 weeks of BCS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For bony pain relief, a single 8 Gy fraction should be favored as equally effective as multiple fractions [58].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Statistical Analysis of Failure Time Data.
Aitkin, M. A., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,875
Survival Analysis Techniques for Censored and Truncated Data
Rao, M. B., Klein, J. P., & Moeschberger, M. L. (1998) · Technometrics · doi:10.2307/1270658 · Cited by 3,617
The Statistical Analysis of Failure Time Data
Kalbfleisch, J. D., & Prentice, R. L. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/9781118032985 · Cited by 3,219
Klein, J. P., & Moeschberger, M. L. (2003) · Statistics for biology and health · doi:10.1007/b97377 · Cited by 1,832
Fallowfield, L. J., Hall, A., Maguire, G. P., & Baum, M. (1990) · BMJ · doi:10.1136/bmj.301.6752.575 · Cited by 750
Does Delay in Starting Treatment Affect the Outcomes of Radiotherapy? A Systematic Review
Huang, J., Barbera, L. C., Brouwers, M. C., Browman, G. P., & Mackillop, W. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.171 · Cited by 592
Population-Based Validation of the Prognostic Model ADJUVANT! for Early Breast Cancer
Olivotto, I. A., Bajdik, C. D., Ravdin, P. M., Speers, C. H., Coldman, A. J., Norris, B. D., Davis, G. J., Chia, S., & Gelmon, K. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.178 · Cited by 566
Self-citationChen, Z., King, W. D., Pearcey, R. G., Kerba, M., & Mackillop, W. J. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.11.016 · Cited by 421
Clarke, D. H., Lê, M. G., Sarrazin, D., Terrier‐Lacombe, M., Fontaine, F., Travagli, J., May-Levin, F., Contesso, G., & Arriagada, R. (1985) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(85)90372-4 · Cited by 408
Flagged first, then by citations
Research works printed but not linked: 1
- O'Reilly S, Olivotto IA: Adjuvant systemic therapy for women with operable breast cancer: Experience in British Columbia, Canada. J Irish Coll Phys Surg 27:177,1998-181,
Cited by
Sorted by citations
Items 101–101 of 101
Diagnosis and management of breast cancer during pregnancy
Hurrell, A., Metodiev, Y., Harries, M., Nanda, S., Nelson‐Piercy, C., & Nana, M. (2026) · The Lancet Obstetrics Gynaecology & Women s Health · doi:10.1016/s3050-5038(26)00216-5
Metadata
- Authors
- Olivotto, I. A., Lesperance, M. L., Truong, P. T., Nichol, A., Berrang, T., Tyldesley, S., Germain, F., Speers, C., Wai, E., Holloway, C., Kwan, W., & Kennecke, H.
- Affiliations
- BC Cancer Agency (CA)
- ORCID
- Venue
- Journal of Clinical Oncology
- Published
- 2009-01-01
- Volume
- 27
- Issue
- 1
- Pages
- 16-23
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2130090226
- Cited by
- 101
- References
- 24
- Citations by year
- 2026: 5 · 2025: 1 · 2024: 2 · 2023: 6 · 2022: 7 · 2021: 10 · 2020: 22 · 2019: 1 · 2018: 6 · 2017: 5 · 2016: 5 · 2015: 3 · 2014: 3 · 2013: 3 · 2012: 7
- FWCI
- 1.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Oncology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Society of Clinical Oncology
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Health Sciences › Medicine › Pathology and Forensic Medicine › Breast Lesions and Carcinomas
- Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
- Keywords
- breast-conserving surgery, radiotherapy, early breast cancer, local recurrence-free survival, distant recurrence-free survival, breast cancer-specific survival, timing of radiotherapy, local control, survival outcomes, matched analysis
- MeSH terms
- Adult, Aged, Aged, 80 and over, Breast Neoplasms, Combined Modality Therapy, Female, Humans, Middle Aged, Neoplasm Staging, Time Factors, Mastectomy, Segmental
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
